Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN)

被引：0
|
作者：
Degardin, M
Bastit, P
Rolland, F
Armand, JP
Chevallier, B
VanGlabbeke, M
Boudillet, J
Tresca, P
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：843 / 843
页数：1
相关论文
共 50 条
  • [1] A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Saxman, S
    Mann, B
    Canfield, V
    Loehrer, P
    Vokes, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 398 - 400
  • [2] Phase II trial of sunitinib in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Choong, N. W.
    Cohen, E. E.
    Kozloff, M. F.
    Taber, D.
    Wade, J. L., III
    Hu, S.
    Ivy, S. P.
    Nichols, K.
    Dekker, A.
    Vokes, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Espinosa, E
    Zamora, P
    Millá, A
    Morales, S
    Molina, R
    Mira, M
    Barón, MG
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (12): : 1054 - 1059
  • [4] An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Degardin, M
    Oliveira, J
    Geoffrois, L
    Rolland, F
    Armand, JP
    Bastit, P
    Chauvergne, J
    Fargeot, P
    van Glabbeke, M
    Lentz, MA
    Tresca, P
    Boudillet, J
    Fumoleau, P
    Cappelaere, P
    ANNALS OF ONCOLOGY, 1998, 9 (10) : 1103 - 1107
  • [5] Phase II trial of everolimus in patients with previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Varadarajan, Prakash
    Kotsakis, Athanasios Panayotis
    Martin, Daniel
    Gutkind, Jorge Silvio
    Gibson, Michael K.
    Argiris, Athanassios
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)
    Limaye, Sewanti
    Riley, Sarah
    Zhao, Sihai
    O'Neill, Anne
    Posner, Marshall
    Adkins, Douglas
    Jaffa, Zachary
    Clark, John
    Haddad, Robert
    ORAL ONCOLOGY, 2013, 49 (08) : 835 - 841
  • [7] A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
    Lee, Ji Hyun
    Heo, Seong Gu
    Ahn, Beung-Chul
    Hong, Min Hee
    Cho, Byoung Chul
    Lim, Sun Min
    Kim, Hye Ryun
    CANCER MEDICINE, 2021, 10 (20): : 7012 - 7020
  • [8] Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Kornek, V
    Scheithauer, W
    Glaser, C
    Toth, J
    Duman, M
    Formanek, M
    Hejna, M
    Kornfehl, J
    ONCOLOGY, 1999, 56 (01) : 24 - 27
  • [9] A phase II study of lapatinib (GW572016) in recurrent/metastatic (RIM) squamous cell carcinoma of the head and neck (SCCHN).
    Abidoye, O. O.
    Cohen, E. E.
    Wong, S. J.
    Kozloff, M. F.
    Nattam, S. R.
    Stenson, K. M.
    Blair, E. A.
    Day, S.
    Dancey, J. E.
    Vokes, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 297S - 297S
  • [10] A phase II study of single agent OSI-7904L in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Hough, B.
    Posner, M.
    Chung, C.
    Hainsworth, J.
    Horan, J.
    Chick, J.
    Gibson, M. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345